Literature DB >> 26988147

Diagnosing and treating HIV-associated sensory neuropathy: a global perspective.

Catherine L Cherry1,2, Antonia L Wadley1, Peter R Kamerman1.   

Abstract

HIV-associated sensory neuropathy (HIV-SN) is a common complication of HIV and remains highly prevalent even with modern HIV management strategies, causing debilitating pain in millions globally. We review HIV-SN diagnosis and management. We suggest most HIV-SN cases are easily recognized using clinical screening tools, with physician assessment and/or specialized testing prioritized for atypical cases. Management aims to prevent further nerve damage and optimize symptom control. Symptom relief is difficult and rarely complete, with a lack of proven pharmacological strategies. Work is needed to clarify optimal use of available medications. This includes understanding the marked placebo effect in HIV-SN analgesic trials and exploring 'responder phenotypes'. Limited data support nondrug strategies including hypnosis, meditation, psychology, physical activity and a positive therapeutic relationship.

Entities:  

Keywords:  HIV; neuropathic pain; neuropathy; nondrug strategies; placebo effect

Mesh:

Year:  2016        PMID: 26988147     DOI: 10.2217/pmt.15.65

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  9 in total

1.  A qualitative exploration of chronic pain and opioid treatment among HIV patients with drug use disorders.

Authors:  Sarina R Isenberg; Allysha C Maragh-Bass; Kathleen Ridgeway; Mary C Beach; Amy R Knowlton
Journal:  J Opioid Manag       Date:  2017 Jan/Feb

2.  Assessment and Management of HIV Distal Sensory Peripheral Neuropathy: Understanding the Symptoms.

Authors:  Joyce K Anastasi; Anna M Pakhomova
Journal:  J Nurse Pract       Date:  2020-03-20       Impact factor: 0.767

3.  Racial and socioeconomic disparities in the symptom reporting of persons living with HIV.

Authors:  Rebecca Schnall; Karolynn Siegel; Haomiao Jia; Susan Olender; Sabina Hirshfield
Journal:  AIDS Care       Date:  2018-01-22

Review 4.  Neuropathy in Human Immunodeficiency Virus: A Review of the Underlying Pathogenesis and Treatment.

Authors:  Lakshya Motwani; Nailah Asif; Apurva Patel; Deepanjali Vedantam; Devyani S Poman
Journal:  Cureus       Date:  2022-06-13

Review 5.  Genetics of HIV-associated sensory neuropathy and related pain in Africans.

Authors:  Huguette Gaelle Ngassa Mbenda; Antonia Wadley; Zane Lombard; Catherine Cherry; Patricia Price; Peter Kamerman
Journal:  J Neurovirol       Date:  2017-05-30       Impact factor: 2.643

6.  Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana.

Authors:  Peter Puplampu; Vincent Ganu; Ernest Kenu; William Kudzi; Patrick Adjei; Leticia Grize; Michael Käser
Journal:  J Neurovirol       Date:  2019-04-26       Impact factor: 2.643

7.  Higher iron stores and the HFE 187C>G variant delay onset of peripheral neuropathy during combination antiretroviral therapy.

Authors:  Asha R Kallianpur; Wanqing Wen; Angelika L Erwin; David B Clifford; Todd Hulgan; Gregory K Robbins
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.752

8.  Magnetic Resonance Imaging as a Biomarker in Diabetic and HIV-Associated Peripheral Neuropathy: A Systematic Review-Based Narrative.

Authors:  Matthew C Evans; Charles Wade; David Hohenschurz-Schmidt; Pete Lally; Albert Ugwudike; Kamal Shah; Neal Bangerter; David J Sharp; Andrew S C Rice
Journal:  Front Neurosci       Date:  2021-09-21       Impact factor: 4.677

9.  Novel RET agonist for the treatment of experimental neuropathies.

Authors:  Hanna Viisanen; Ulpukka Nuotio; Oleg Kambur; Arun Kumar Mahato; Viljami Jokinen; Tuomas Lilius; Wei Li; Hélder A Santos; Mati Karelson; Pekka Rauhala; Eija Kalso; Yulia A Sidorova
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.